173 related articles for article (PubMed ID: 2461592)
1. Biotherapy of chronic myelogenous leukemia with interferon.
Ozer H
Semin Oncol; 1988 Oct; 15(5 Suppl 5):14-20. PubMed ID: 2461592
[No Abstract] [Full Text] [Related]
2. Interferon induced cytogenetic improvement in CGL patients in haematological relapse post allograft.
Aitchison R; Collins P; Newland AC
Bone Marrow Transplant; 1990 Dec; 6(6):453. PubMed ID: 2097016
[No Abstract] [Full Text] [Related]
3. Autologous blood stem cell transplantation followed by recombinant alpha interferon as treatment for patients with high-risk chronic myelogenous leukemia. A report of 32 cases.
Reiffers J; Montastruc M; Marit G; Cony-Makhoul P; Faberes C; Bilhou-Nabera C; Gharbi MJ; Bernard P; Vezon G; Broustet A
Leuk Lymphoma; 1993; 11 Suppl 1():297-9. PubMed ID: 8251911
[TBL] [Abstract][Full Text] [Related]
4. [Interferon and chronic myeloid leukemia].
Steegmann JL; Pérez Sánchez M; Fernández-Rañada JM
Sangre (Barc); 1990 Jun; 35(3):213-7. PubMed ID: 2204124
[No Abstract] [Full Text] [Related]
5. All is not lost in accelerated phase/blast crisis and after tyrosine kinase inhibitors fail in chronic myeloid leukaemia: a retrospective study of allogeneic stem cell transplant outcomes in Australia and New Zealand.
Kruger P; Cooney J; Nivison-Smith I; Dodds A; Bardy P; Ma D; Szer J; Durrant S
Bone Marrow Transplant; 2016 Oct; 51(10):1400-1403. PubMed ID: 27214080
[No Abstract] [Full Text] [Related]
6. [The treatment of chronic myeloleukemia with recombinant alfa-2 interferon].
Strozha I; Petukhov V; Bondare D; Feldmane G; Duks A; Teilane I; Medne I; Mauritsas M; Grinberga L
Ter Arkh; 1993; 65(10):62-6. PubMed ID: 8296238
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of blast crisis of chronic myeloid leukemia].
Kotlarek-Haus S
Acta Haematol Pol; 1992; 23(2 Suppl 1):23-9. PubMed ID: 1488869
[TBL] [Abstract][Full Text] [Related]
8. Interferon alfa-2c in chronic myelogenous leukemia (CML): hematologic, cytogenetic and molecular-genetic response of patients with chronic phase CML previously resistant to therapy with interferon gamma.
Herrmann F; Jonas D; Helfrich SG; Lindemann A; Schleiermacher E; Mertelsmann R
Blut; 1990 Oct; 61(4):226-31. PubMed ID: 2121299
[TBL] [Abstract][Full Text] [Related]
9. [The treatment of chronic myeloid leukemia in chronic phase with interferons].
Guilhot F
Pathol Biol (Paris); 1988 Dec; 36(10):1179-81. PubMed ID: 3070457
[No Abstract] [Full Text] [Related]
10. CML: new biologic therapies, endpoints and questions.
Martin A; Cheson BD
Oncology (Williston Park); 1987 Sep; 1(7):12-3, 16. PubMed ID: 3152809
[No Abstract] [Full Text] [Related]
11. An accelerrated-phase CML patient with e19a2 junction of BCR/ABL gene - the first case of transplanted CML with micro bcr.
Polák J; Koza V; Cetkovský P; Haskovec C
Bone Marrow Transplant; 2000 May; 25(10):1109-10. PubMed ID: 10828875
[No Abstract] [Full Text] [Related]
12. [Chronic myeloid leukemia: a decade of progress].
Cervantes F
Med Clin (Barc); 1990 Jan; 94(1):27-35. PubMed ID: 1692385
[No Abstract] [Full Text] [Related]
13. Polyclonal hematopoiesis in interferon-induced cytogenetic remissions of chronic myelogenous leukemia.
Claxton D; Deisseroth A; Talpaz M; Reading C; Kantarjian H; Trujillo J; Stass S; Gooch G; Spitzer G
Blood; 1992 Feb; 79(4):997-1002. PubMed ID: 1371081
[TBL] [Abstract][Full Text] [Related]
14. Sequential treatment of Ph-positive chronic myeloid leukemia with interferon gamma and interferon alpha.
Russo D; Fanin R; Zuffa E; Damiani D; Gallizia C; Michieli M; Testoni N; Benfenati D; Visani G; Zaccaria A
Haematologica; 1990; 75(4):334-9. PubMed ID: 2125966
[TBL] [Abstract][Full Text] [Related]
15. Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemia.
Przepiorka D; Khouri I; Thall P; Mehra R; Lee MS; Ippoliti C; Giralt S; Gajewski J; van Besien K; Andersson B; Körbling M; Deisseroth AB; Champlin R
Bone Marrow Transplant; 1999 May; 23(10):977-81. PubMed ID: 10373061
[TBL] [Abstract][Full Text] [Related]
16. [Recombinant alpha-interferon (reaferon) in the treatment of patients with chronic myeloleukemia].
Khoroshko ND; Savchenko VG; Kholopova EI; Kotel'nikov VM; Zakharova AV; Semenova EA; Marchenko VI
Ter Arkh; 1990; 62(7):41-7. PubMed ID: 2251664
[TBL] [Abstract][Full Text] [Related]
17. Biologic therapy of chronic myelogenous leukemia.
Kantarjian HM; Talpaz M; Gutterman J
Oncology (Williston Park); 1987 Sep; 1(7):35-40, 48-9, 52. PubMed ID: 3152810
[TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic myelogenous leukemia with interferons: hematologic, cellular, and genetic investigations.
Opalka B; Kloke O; Wandl U; Becher R; Niederle N
Haematol Blood Transfus; 1989; 32():134-8. PubMed ID: 2516494
[No Abstract] [Full Text] [Related]
19. Long-term response in accelerated-phase chronic myelogenous leukemia with protracted splenic irradiation and alpha-interferon.
Girinsky T; Bonomi M; Bayle C
Am J Hematol; 1999 Dec; 62(4):262. PubMed ID: 10589089
[No Abstract] [Full Text] [Related]
20. A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
Elmaagacli AH; Beelen DW; Schaefer UW
Bone Marrow Transplant; 1997 Dec; 20(12):1045-55. PubMed ID: 9466277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
